Connect with NCQA

twitter linkedin facebook google+ youtube pinterest

Report an Error

Use NCQA’s Feedback Form to report a broken link, or content error.

Statin Therapy for Patients with Cardiovascular Disease and Diabetes

These HEDIS Measures

Statin Therapy for Patients with Cardiovascular Disease: Assesses males 21–75 years of age and females 40–75 years of age who have clinical atherosclerotic cardiovascular disease (ASCVD) and who received and adhered to statin therapy.

Statin Therapy for Patients with Diabetes: Assesses adults 40–75 years of age with diabetes, who do not have clinical ASCVD and who received and adhered to statin therapy.

The Bottom Line

Cardiovascular disease is the leading cause of death in the United States. It is estimated that 92.1 million American adults have one or more types of cardiovascular disease (Benjamin et al., 2017). People with diabetes also have elevated cardiovascular risk, thought to be due in part to elevations in unhealthy cholesterol levels. Having unhealthy cholesterol levels places people at significant risk for developing ASCVD.

Statins are a class of drugs that lower blood cholesterol. American College of Cardiology and American Heart Association (ACC/AHA) guidelines state that statins of moderate or high intensity are recommended for adults with established clinical ASCVD. The American Diabetes Association and ACC/AHA guidelines also recommend statins for primary prevention of cardiovascular disease in patients with diabetes, based on age and other risk factors. Guidelines also state that adherence to statins will aid in ASCVD risk reduction in both populations.

References:

  1. Benjamin, E.J., et al. 2017. “Heart disease and stroke statistics-2017 update: a report from the American Heart Association.” Circulation 135(10): e146–e603. doi:10.1161/CIR.0000000000000485.
tables
STATIN THERAPY FOR PATIENTS WITH DIABETES - RECEIVED STATIN THERAPY
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016 60.2 58.9 60.2 70.7 67.8
STATIN THERAPY FOR PATIENTS WITH DIABETES - STATIN ADHERENCE 80%
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016 66.5 67.5 59.3 75.3 77.6
STATIN THERAPY FOR PATIENTS WITH CARDIOVASCULAR DISEASE - RECEIVED STATIN THERAPY
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016 79.2 79.9 74.7 77.3 76.8
STATIN THERAPY FOR PATIENTS WITH CARDIOVASCULAR DISEASE - STATIN ADHERENCE 80%
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016 69.8 72.0 60.9 75.5 76.7